Literature DB >> 3003382

Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice.

J A Mercer, D H Spector.   

Abstract

We have characterized the progress of acute murine cytomegalovirus (MCMV) infection in the spleen, liver, and salivary gland of susceptible (BALB/c) and resistant (C3H) strains of mice after intraperitoneal inoculation. Viral replication was analyzed by virus titration, infectious-center assays, and in situ cytohybridization with cloned subgenomic fragments of the MCMV genome. The most striking differences between strains were observed in the spleen. At 24 h postinfection (p.i.), both strains had a similar number of infected spleen cells. At 48 h p.i., BALB/c mice showed marked dissemination of the splenic infection which continued until 96 h p.i. In contrast, the number of infected C3H spleen cells did not increase from the 24-h level but declined later on. This early block in dissemination of MCMV infection in C3H mouse spleens was not a result of the H-2k haplotype, as BALB.K (H-2k) mice, which show an intermediate level of resistance to MCMV infection, exhibited dissemination of the infection between 24 and 48 h p.i., albeit at a reduced level. However, between 72 and 96 h p.i., we observed a decline in the number of infected spleen cells in BALB.K mice similar to that observed in C3H mice. We also demonstrated by Southern blot analysis of DNA from the infected spleen cells that the termini of the MCMV genome fuse after in vivo infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003382      PMCID: PMC252762     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Fusion of the termini of the murine cytomegalovirus genome after infection.

Authors:  J R Marks; D H Spector
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

2.  Transcription in mouse embryo cells permissively infected by murine cytomegalovirus.

Authors:  J R Marks; J A Mercer; D H Spector
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

3.  Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection.

Authors:  G M Keil; A Ebeling-Keil; U H Koszinowski
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

4.  Involvement of natural killer cells in the pathogenesis of murine cytomegalovirus interstitial pneumonitis and the immune response to infection.

Authors:  G V Quinnan; J F Manischewitz; N Kirmani
Journal:  J Gen Virol       Date:  1982-01       Impact factor: 3.891

5.  Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse.

Authors:  J E Chalmer; J S Mackenzie; N F Stanley
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

6.  Lethal infection with murine cytomegalovirus after early viral replication in the spleen.

Authors:  D A Katzenstein; G S Yu; M C Jordan
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

7.  Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain).

Authors:  J A Mercer; J R Marks; D H Spector
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

Review 8.  Latent infection and the elusive cytomegalovirus.

Authors:  M C Jordan
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

9.  Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice.

Authors:  J F Bukowski; B A Woda; R M Welsh
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.

Authors:  J F Bukowski; J F Warner; G Dennert; R M Welsh
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more
  17 in total

1.  Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

Authors:  J A Mercer; C A Wiley; D H Spector
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  The effects of protein malnutrition on the pathogenesis of murine cytomegalovirus disease.

Authors:  H K Teo; P Price; J M Papadimitriou
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

3.  A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.

Authors:  Pranay Dogra; Mindy Miller-Kittrell; Elisabeth Pitt; Joseph W Jackson; Tom Masi; Courtney Copeland; Shuen Wu; William E Miller; Tim Sparer
Journal:  J Gen Virol       Date:  2016-09-13       Impact factor: 3.891

Review 4.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

5.  Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.

Authors:  Christopher S Morello; Ming Ye; Stephanie Hung; Laura A Kelley; Deborah H Spector
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.

Authors:  Xue-Feng Liu; Suchitra Swaminathan; Shixian Yan; Flora Engelmann; Darryl Adelaide Abbott; Luke Andrew VanOsdol; Taylor Heald-Sargent; Longhui Qiu; Qing Chen; Andre Iovane; Zheng Zhang; Michael M Abecassis
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

7.  DNA immunization confers protection against murine cytomegalovirus infection.

Authors:  J C González Armas; C S Morello; L D Cranmer; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Effect of a retroviral immunodeficiency syndrome on murine cytomegalovirus-induced hepatitis.

Authors:  C D Peacock; S D Olver; P Price
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

9.  Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.

Authors:  Ming Ye; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 10.  MHC class I immune evasion in MCMV infection.

Authors:  Carmen M Doom; Ann B Hill
Journal:  Med Microbiol Immunol       Date:  2008-03-11       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.